A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects
Clinical trial NCT03229291 · COMPLETED
Trial details
- NCT number
- NCT03229291
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-03
- Primary completion
- 2017-06-11
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.